Inside the human cancer tyrosine phosphatome
Authors:
- 23 December 2010
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 11 (1) , 35-49
Abstract
The protein tyrosine phosphatase (Ptp) family comprises 107 members that are classified into four classes on the basis of the amino acid sequences of their catalytic domains. Recent evidence has shown that members of the Ptp family are key components of tumorigenesis in various human cancers, exerting either putative oncogenic or tumour suppressive functions, depending on the cellular context. Genetic alterations such as mutation, deletion and amplification are the most important features for putative oncogenic PTPs, whereas in most cases epigenetic modifications such as DNA methylation counter the tumour suppressive functions of PTPs. Recent advances have begun to decipher the molecular mechanisms by which putative oncogenic PTPs may drive tumorigenesis in human cells. Proliferation, survival, apoptosis, vesicular trafficking, adhesion, migration and invasion are all altered by the aberrant functions of PTPs during tumour development. Evidence for an association between PTPs and an increased risk of developing cancer remains controversial and elusive. Here, we focus on the pertinent genetic and functional data that support the relevance of members of the Ptp family to human cancer. PTP inhibitors are currently being developed. However, a better understanding of the basic biology of PTPs in human tumour development will be required to improve the therapeutic use of such inhibitors.Keywords
This publication has 193 references indexed in Scilit:
- Genome remodelling in a basal-like breast cancer metastasis and xenograftNature, 2010
- An Unbiased Screen Identifies DEP-1 Tumor Suppressor as a Phosphatase Controlling EGFR EndocytosisCurrent Biology, 2009
- Acquisition of a Potent and Selective TC-PTP Inhibitor via a Stepwise Fluorophore-Tagged Combinatorial Synthesis and Screening StrategyJournal of the American Chemical Society, 2009
- Tyrosine phosphorylation: thirty years and countingCurrent Opinion in Cell Biology, 2009
- Large-Scale Structural Analysis of the Classical Human Protein Tyrosine PhosphatomeCell, 2009
- Expression of the putative tumor suppressor genePTPN13/PTPL1is an independent prognostic marker for overall survival in breast cancerInternational Journal of Cancer, 2008
- PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic β-catenin and affects membrane distribution of β-catenin/E-cadherin complexes in cancer cellsCellular Signalling, 2008
- PTPL1: a large phosphatase with a split personalityCancer and Metastasis Reviews, 2008
- Targeting PTPs with small molecule inhibitors in cancer treatmentCancer and Metastasis Reviews, 2008
- High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization studyVirchows Archiv, 2007